The role of Tec family kinases in myeloid cells

International Archives of Allergy and Immunology

Volumn 134, Issue 1, 2004, Pages 65-78

  Schmidt, Uwe ^a   Boucheron, Nicole ^a   Unger, Bernd ^a,b   Ellmeier, Wilfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b BMT Research Vienna   (Austria)

Author keywords

Hematopoiesis; Knockout mice; Myeloid cells; Protein tyrosine kinases; Signaling; Tec family kinases; X linked agammaglobulinemia

Indexed keywords

PROTEIN TYROSINE KINASE;

ALLERGIC REACTION; APOPTOSIS; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DENDRITIC CELL; ENZYME ACTIVITY; ERYTHROID CELL; HEMATOPOIETIC CELL; IMMUNOSTIMULATION; MACROPHAGE; MAST CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; THROMBOCYTE;

BLOOD PLATELETS; DENDRITIC CELLS; ENZYME ACTIVATION; ERYTHROID CELLS; HUMANS; MAST CELLS; MYELOID CELLS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 2542637189     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078339     Document Type: Review

References (117)

1. Mano H, Ishikawa F, Nishida J, Hirai H, Takaku F: A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. Oncogene 1990;5:1781-1786.
2. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, et al: Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;72:279-290.
3. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarstrom L, Kinnon C, Levinsky R, Bobrow M, et al: The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993;361:226-233.
4. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG, et al: Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993;261:358-361.
5. Yamada N, Kawakami Y, Kimura H, Fukamachi H, Baier G, Altman A, Kato T, Inagaki Y, Kawakami T: Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells. Biochem Biophys Res Commun 1993;192:231-240.
6. Tamagnone L, Lahtinen I, Mustonen T, Virtaneva K, Francis F, Muscatelli F, Alitalo R, Smith CI, Larsson C, Alitalo K: BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 1994;9:3683-3688.
7. Robinson D, He F, Pretlow T, Kung HJ: A tyrosine kinase profile of prostate carcinoma. Proc Natl Acad Sci USA 1996;93:5958-5962.
8. Siliciano JD, Morrow TA, Desiderio SV: itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci USA 1992;89:11194-11198.
9. Heyeck SD, Berg LJ: Developmental regulation of a murine T-cell-specific tyrosine kinase gene, Tsk. Proc Natl Acad Sci USA 1993;90:669-673.
10. Haire RN, Ohta Y, Lewis JE, Fu SM, Kroisel P, Litman GW: TXK, a novel human tyrosine kinase expressed in T cells shares sequence identity with Tec family kinases and maps to 4p12. Hum Mol Genet 1994;3:897-901.
11. Hu Q, Davidson D, Schwartzberg PL, Macchiarini F, Lenardo MJ, Bluestone JA, Matis LA: Identification of Rlk, a novel protein tyrosine kinase with predominant expression in the T cell lineage. J Biol Chem 1995;270:1928-1934.
12. Smith CI, Islam TC, Mattsson PT, Mohamed AJ, Nore BF, Vihinen M: The Tec family of cytoplasmic tyrosine kinases: Mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays 2001;23:436-446.
13. Schlessinger J: SH2/SH3 signaling proteins. Curr Opin Genet Dev 1994;4:25-30.
14. Mayer BJ, Gupta R: Functions of SH2 and SH3 domains. Curr Top Microbiol Immunol 1998;228:1-22.
15. Andreotti AH, Bunnell SC, Feng S, Berg LJ, Schreiber SL: Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature 1997;385:93-97.
16. Cheng G, Ye ZS, Baltimore D: Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc Natl Acad Sci USA 1994;91:8152-8155.
17. Debnath J, Chamorro M, Czar MJ, Schaeffer EM, Lenardo MJ, Varmus HE, Schwartzberg PL: rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases. Mol Cell Biol 1999;19:1498-1507.
18. Mano H, Mano K, Tang B, Koehler M, Yi T, Gilbert DJ, Jenkins NA, Copeland NG, Ihle JN: Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near Kit. Oncogene 1993;8:417-424.
19. Kawakami Y, Yao L, Miura T, Tsukada S, Witte ON, Kawakami T: Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking. Mol Cell Biol 1994;14:5108-5113.
20. Kawakami Y, Yao L, Tashiro M, Gibson S, Mills GB, Kawakami T: Activation and interaction with protein kinase C of a cytoplasmic tyrosine kinase, Itk/Tsk/Emt, on Fc epsilon RI cross-linking on mast cells. J Immunol 1995;155:3556-3562.
21. Sommers CL, Huang K, Shores EW, Grinberg A, Charlick DA, Kozak CA, Love PE: Murine txk: A protein tyrosine kinase gene regulated by T cell activation. Oncogene 1995;11:245-251.
22. Kazama A, Mano H, Morishita Y, Mori S: High expression of the tec gene product in murine testicular germ cells and erythroblasts. Pathol Int 1996;46:341-347.
23. van Dijk TB, van Den Akker E, Amelsvoort MP, Mano H, Lowenberg B, von Lindern M: Stem cell factor induces phosphatidylinositol 3′-kinase- dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells. Blood 2000;96:3406-3413.
24. Whyatt D, Lindeboom F, Karis A, Ferreira R, Milot E, Hendriks R, de Bruijn M, Langeveld A, Gribnau J, Grosveld F, Philipsen S: An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells. Nature 2000;406:519-524.
25. Quek LS, Bolen J, Watson SP: A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen. Curr Biol 1998;8:1137-1140.
26. Laffargue M, Monnereau L, Tuech J, Ragab A, Ragab-Thomas J, Payrastre B, Raynal P, Chap H: Integrin-dependent tyrosine phosphorylation and cytoskeletal translocation of Tec in thrombin-activated platelets. Biochem Biophys Res Commun 1997;238:247-251.
27. Kaukonen J, Lahtinen I, Laine S, Alitalo K, Palotie A: BMX tyrosine kinase gene is expressed in granulocytes and myeloid leukaemias. Br J Haematol 1996;94:455-460.
28. Weil D, Power MA, Smith SI, Li CL: Predominant expression of murine Bmx tyrosine kinase in the granulo-monocytic lineage. Blood 1997;90:4332-4340.
29. Horwood NJ, Mahon T, McDaid JP, Campbell J, Mano H, Brennan FM, Webster D, Foxwell BM: Bruton's tyrosine kinase is required for lipopolysaccharide- induced tumor necrosis factor alpha production. J Exp Med 2003;197:1603-1611.
30. Lachance G, Levasseur S, Naccache PH: Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. Implication of phosphatidylinositol 3-kinases. J Biol Chem 2002;277:21537-21541.
31. Gagliardi MC, Finocchi A, Orlandi P, Cursi L, Cancrini C, Moschese V, Miyawaki T, Rossi P: Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function. Clin Exp Immunol 2003;133:115-122.
32. Phillips RL, Ernst RE, Brunk B, Ivanova N, Mahan MA, Deanehan JK, Moore KA, Overton GC, Lemischka IR: The genetic program of hematopoietic stem cells. Science 2000;288:1635-1640.
33. Yang EJ, Yoon JH, Chung KC: Bruton's tyrosine kinase phosphorylates CREB at Ser-133 during neuronal differentiation in immortalized hippocampal progenitor cells. J Biol Chem 2004;279:1827-1837.
34. Schaeffer EM, Schwartzberg PL: Tec family kinases in lymphocyte signaling and function. Curr Opin Immunol 2000;12:282-288.
35. Lewis CM, Broussard C, Czar MJ, Schwartzberg PL: Tec kinases: Modulators of lymphocyte signaling and development. Curr Opin Immunol 2001;13:317-325.
36. Miller AT, Berg LJ: New insights into the regulation and function of Tec family tyrosine kinases in the immune system. Curr Opin Immunol 2002;14:331-340.
37. Bunnell SC, Diehn M, Yaffe MB, Findell PR, Cantley LC, Berg LJ: Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. J Biol Chem 2000;275:2219-2230.
38. Guo B, Kato RM, Garcia-Lloret M, Wahl MI, Rawlings DJ: Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity 2000;13:243-253.
39. Shan X, Czar MJ, Bunnell SC, Liu P, Liu Y, Schwartzberg PL, Wange RL: Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol Cell Biol 2000;20:6945-6957.
40. Woods ML, Kivens WJ, Adelsman MA, Qiu Y, August A, Shimizu Y: A novel function for the Tec family tyrosine kinase Itk in activation of beta 1 integrins by the T-cell receptor. EMBO J 2001;20:1232-1244.
41. Takata M, Kurosaki T: A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J Exp Med 1996;184:31-40.
42. 2+ following B-cell receptor activation. EMBO J 1998;17:1973-1985.
43. Liu KQ, Bunnell SC, Gurniak CB, Berg LJ: T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J Exp Med 1998;187:1721-1727.
44. Schaeffer EM, Debnath J, Yap G, McVicar D, Liao XC, Littman DR, Sher A, Varmus HE, Lenardo MJ, Schwartzberg PL: Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 1999;284:638-641.
45. Donnadieu E, Lang V, Bismuth G, Ellmeier W, Acuto O, Michel F, Trautmann A: Differential roles of Lck and Itk in T cell response to antigen recognition revealed by calcium imaging and electron microscopy. J Immunol 2001;166:5540-5549.
46. Hata D, Kawakami Y, Inagaki N, Lantz CS, Kitamura T, Khan WN, Maeda-Yamamoto M, Miura T, Han W, Hartman SE, Yao L, Nagai H, Goldfeld AE, Alt FW, Galli SJ, Witte ON, Kawakami T: Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med 1998;187:1235-1247.
47. Su YW, Zhang Y, Schweikert J, Koretzky GA, Reth M, Wienands J: Interaction of SLP adaptors with the SH2 domain of Tec family kinases. Eur J Immunol 1999;29:3702-3711.
48. Takesono A, Finkelstein LD, Schwartzberg PL: Beyond calcium: New signaling pathways for Tec family kinases. J Cell Sci 2002;115:3039-3048.
49. Lucas JA, Miller AT, Atherly LO, Berg LJ: The role of Tec family kinases in T cell development and function. Immunol Rev 2003;191:119-138.
50. Tsai YT, Su YH, Fang SS, Huang TN, Qiu Y, Jou YS, Shih HM, Kung HJ, Chen RH: Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation. Mol Cell Biol 2000;20:2043-2054.
51. Mahajan S, Vassilev A, Sun N, Ozer Z, Mao C, Uckun FM: Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells. J Biol Chem 2001;276:31216-31228.
52. Yang W, Desiderio S: BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc Natl Acad Sci USA 1997;94:604-609.
53. Webb CF, Yamashita Y, Ayers N, Evetts S, Paulin Y, Conley ME, Smith EA: The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J Immunol 2000;165:6956-6965.
54. Perez-Villar JJ, O'Day K, Hewgill DH, Nadler SG, Kanner SB: Nuclear localization of the tyrosine kinase Itk and interaction of its SH3 domain with karyopherin alpha (Rch 1alpha). Int Immunol 2001;13:1265-1274.
55. Takeba Y, Nagafuchi H, Takeno M, Kashiwakura J, Suzuki N: Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcription. J Immunol 2002;168:2365-2370.
56. Maas A, Hendriks RW: Role of Bruton's tyrosine kinase in B cell development. Dev Immunol 2001;8:171-181.
57. Rawlings DJ: Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin Immunol 1999;91:243-253.
58. Mekori YA, Metcalfe DD: Mast cells in innate immunity. Immunol Rev 2000;173:131-140.
59. Costello PS, Turner M, Walters AE, Cunningham CN, Bauer PH, Downward J, Tybulewicz VL: Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 1996;13:2595-2605.
60. 2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells. J Immunol 1997;158:2350-2355.
61. Kawakami Y, Kitaura J, Satterthwaite AB, Kato RM, Asai K, Hartman SE, Maeda-Yamamoto M, Lowell CA, Rawlings DJ, Witte ON, Kawakami T: Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J Immunol 2000;165:1210-1219.
62. Dvorak AM, Miura T, Letourneau L, Ishizaka T, Kawakami T: Spontaneous degranulation of cultured bone-marrow-derived immature mast cells from X-linked immunodeficient (Xid) mice. Int Arch Allergy Immunol 1996;111:118-125.
63. Kawakami Y, Miura T, Bissonnette R, Hata D, Khan WN, Kitamura T, Maeda-Yamamoto M, Hartman SE, Yao L, Alt FW, Kawakami T: Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc Natl Acad Sci USA 1997;94:3938-3942.
64. Hata D, Kitaura J, Hartman SE, Kawakami Y, Yokota T, Kawakami T: Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells. Dependence on the c-Jun N-terminal kinase activation pathway. J Biol Chem 1998;273:10979-10987.
65. Kitaura J, Asai K, Maeda-Yamamoto M, Kawakami Y, Kikkawa U, Kawakami T: Akt-dependent cytokine production in mast cells. J Exp Med 2000;192:729-740.
66. Jackson SP, Nesbitt WS, Kulkarni S: Signaling events underlying thrombus formation. J Thromb Haemost 2003;1:1602-1612.
67. Nieswandt B, Watson SP: Platelet-collagen interaction: Is GPVI the central receptor? Blood 2003;102:449-461.
68. Melford SK, Turner M, Briddon SJ, Tybulewicz VL, Watson SP: Syk and Fyn are required by mouse megakaryocytes for the rise in intracellular calcium induced by a collagen-related peptide. J Biol Chem 1997;272:27539-27542.
69. Ezumi Y, Shindoh K, Tsuji M, Takayama H: Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets. J Exp Med 1998;188:267-276.
70. Briddon SJ, Melford SK, Turner M, Tybulewicz V, Watson SP: Collagen mediates changes in intracellular calcium in primary mouse megakaryocytes through syk-dependent and -independent pathways. Blood 1999;93:3847-3855.
71. Briddon SJ, Watson SP: Evidence for the involvement of p59fyn and p53/56lyn in collagen receptor signalling in human platelets. Biochem J 1999;338/1:203-209.
72. Watson SP, Gibbins J: Collagen receptor signalling in platelets: Extending the role of the ITAM. Immunol Today 1998;19:260-264.
73. Hamazaki Y, Kojima H, Mano H, Nagata Y, Todokoro K, Abe T, Nagasawa T: Tec is involved in G protein-coupled receptor- and integrin-mediated signalings in human blood platelets. Oncogene 1998;16:2773-2779.
74. Oda A, Ikeda Y, Ochs HD, Druker BJ, Ozaki K, Handa M, Ariga T, Sakiyama Y, Witte ON, Wahl MI: Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking. Blood 2000;95:1663-1670.
75. Atkinson BT, Ellmeier W, Watson SP: Tec regulates platelet activation by GPVI in the absence of Btk. Blood 2003;102:3592-3599.
76. Laffargue M, Ragab-Thomas JM, Ragab A, Tuech J, Missy K, Monnereau L, Blank U, Plantavid M, Payrastre B, Raynal P, Chap H: Phosphoinositide 3-kinase and integrin signalling are involved in activation of Bruton tyrosine kinase in thrombin-stimulated platelets. FEBS Lett 1999;443:66-70.
77. Pasquet JM, Quek L, Stevens C, Bobe R, Huber M, Duronio V, Krystal G, Watson SP: Phosphatidylinositol 3,4,5-trisphosphate regulates Ca(2+) entry via btk in platelets and megakaryocytes without increasing phospholipase C activity. EMBO J 2000;19:2793-2802.
78. Gross BS, Wilde JI, Quek L, Chapel H, Nelson DL, Watson SP: Regulation and function of WASp in platelets by the collagen receptor, glycoprotein VI. Blood 1999;94:4166-4176.
79. Oda A, Ochs HD, Druker BJ, Ozaki K, Watanabe C, Handa M, Miyakawa Y, Ikeda Y: Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets. Blood 1998;92:1852-1858.
80. Crosby D, Poole AW: Interaction of Bruton's tyrosine kinase and protein kinase Ctheta in platelets. Cross-talk between tyrosine and serine/threonine kinases. J Biol Chem 2002;277:9958-9965.
81. Mukhopadhyay S, Ramars AS, Dash D: Bruton's tyrosine kinase associates with the actinbased cytoskeleton in activated platelets. J Cell Biochem 2001;81:659-665.
82. Mukhopadhyay S, Ramars AS, Ochs HD, Dash D: Bruton's tyrosine kinase is a substrate of calpain in human platelets. FEBS Lett 2001;505:37-41.
83. Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD: Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol 2001;114:141-149.
84. Bobe R, Wilde JI, Maschberger P, Venkateswarlu K, Cullen PJ, Siess W, Watson SP: Phosphatidylinositol 3-kinase-dependent translocation of phospholipase Cgamma2 in mouse megakaryocytes is independent of Bruton tyrosine kinase translocation. Blood 2001;97:678-684.
85. Suzuki-Inoue K, Inoue O, Frampton J, Watson SP: Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: Involvement of PLCgamma1 and PI3-kinase. Blood 2003;102:1367-1373.
86. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995;83:59-67.
87. Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K: Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 1998;93:397-409.
88. Flanagan JG, Chan DC, Leder P: Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 1991;64:1025-1035.
89. Kazama A, Mano H, Morishita Y, Mori S: High expression of the tec gene product in murine testicular germ cells and erythroblasts. Pathol Int 1996;46:341-347.
90. van Dijk TB, van Den Akker E, Amelsvoort MP, Mano H, Lowenberg B, von Lindern M: Stem cell factor induces phosphatidylinositol 3′-kinase- dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells. Blood 2000;96:3406-3413.
91. Whyatt D, Lindeboom F, Karis A, Ferreira R, Milot E, Hendriks R, de Bruijn M, Langeveld A, Gribnau J, Grosveld F, Philipsen S: An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells. Nature 2000;406:519-524.
92. Schmidt U, van den Akker E, Parren-van Amelsvoort M, Litos G, de Bruijn M, Gutiérrez L, Hendriks RW, Ellmeier W, Löwenberg B, Beug H, von Lindern M: Btk is required for an efficient response to erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors. J Exp Med 2004;199:785-795.
93. Vassilev A, Ozer Z, Navara C, Mahajan S, Uckun FM: Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex. J Biol Chem 1999;274:1646-1656.
94. Pan S, An P, Zhang R, He X, Yin G, Min W: Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: Role in endothelial cell migration and angiogenesis. Mol Cell Biol 2002;22:7512-7513.
95. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
96. Aderem A, Underhill DM: Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999;17:593-623.
97. Nathan C, Shiloh MU: Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000;97:8841-8848.
98. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998;282:2085-2088.
99. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-869.
100. Jefferies CA, Doyle S, Brunner C, Dunne A, Brint E, Wietek C, Walch E, Wirth T, O'Neill LA: Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol Chem 2003;278:26258-26264.
101. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA: Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001;413:78-83.
102. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145.
103. Mukhopadhyay S, Mohanty M, Mangla A, George A, Bal V, Rath S, Ravindran B: Macrophage effector functions controlled by Bruton's tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance. J Immunol 2002;168:2914-2921.
104. Zhang JS, Feng WG, Li CL, Wang XY, Chang ZL: NF-kappa B regulates the LPS-induced expression of interleukin 12 p40 in murine peritoneal macrophages: Roles of PKC, PKA, ERK, p38 MAPK, and proteasome. Cell Immunol 2000;204:38-45.
105. Mahajan S, Ghosh S, Sudbeck EA, Zheng Y, Downs S, Hupke M, Uckun FM: Rational design and synthesis of a novel antileukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-betahydroxy-beta-methyl-N-(2, 5-dibromophenyl) propenamide]. J Biol Chem 1999;274:9587-9599.
106. Petro JB, Rahman SM, Ballard DW, Khan WN: Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J Exp Med 2000;191:1745-1754.
107. Petro JB, Khan WN: Phospholipase C-gamma 2 couples Bruton's tyrosine kinase to the NF-kappaB signaling pathway in B lymphocytes. J Biol Chem 2001;276:1715-1719.
108. Saijo K, Mecklenbrauker I, Santana A, Leitger M, Schmedt C, Tarakhovsky A: Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. J Exp Med 2002;195:1647-1652.
109. Amoras AL, Kanegane H, Miyawaki T, Vilela MM: Defective Fc-, CR1- and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients. J Investig Allergol Clin Immunol 2003;13:181-188.
110. Mukhopadhyay S, George A, Bal V, Ravindran B, Rath S: Bruton's tyrosine kinase deficiency in macrophages inhibits nitric oxide generation leading to enhancement of IL-12 induction. J Immunol 1999;163:1786-1792.
111. Mukhopadhyay S, Sahoo PK, George A, Bal V, Rath S, Ravindran B: Delayed clearance of filarial infection and enhanced Th1 immunity due to modulation of macrophage APC functions in xid mice. J Immunol 1999;163:875-883.
112. Cicchetti G, Allen PG, Glogauer M: Chemotactic signaling pathways in neutrophils: From receptor to actin assembly. Crit Rev Oral Biol Med 2002;13:220-228.
113. Burg ND, Pillinger MH: The neutrophil: Function and regulation in innate and humoral immunity. Clin Immunol 2001;99:7-17.
114. Gilbert C, Levasseur S, Desaulniers P, Dusseault AA, Thibault N, Bourgoin SG, Naccache PH: Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. II. Effects of LFM-A13, a specific Btk inhibitor. J Immunol 2003;170:5235-5243.
115. Saito K, Tolias KF, Saci A, Koon HB, Humphries LA, Scharenberg A, Rawlings DJ, Kinet JP, Carpenter CL: BTK regulates PtdIns-4,5-P2 synthesis: Importance for calcium signaling and PI3K activity. Immunity 2003;19:669-678.
116. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
117. Kang SW, Wahl MI, Chu J, Kitaura J, Kawakami Y, Kato RM, Tabuchi R, Tarakhovsky A, Kawakami T, Turck CW, Witte ON, Rawlings DJ: PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J 2001;20:5692-5702.